FDA is leveraging lessons learned from COVID-19 to improve supply chain resiliency and develop new solutions.
Dr. Heather Agler, Senior Program Manager, CDRH, FDA
The COVID-19 pandemic highlighted critical supply chain challenges as health agencies like the Food and Drug Administration faced new, unforeseen demands. Dr. Heather Agler joins us from HIMSS 2022 to discuss how FDA investigated data and developed new methods to better inform stockpiling strategies for critical supplies like ventilators, personal protective equipment (PPE) and more, as well as share her thoughts on what comes next in health IT.
